@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix Protein: . @prefix mgi: . @prefix geneProductOf: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: mgi:1859852; a Protein: . sub:_2 geneProductOf: mgi:104853; a Protein: . sub:_3 occursIn: obo:EFO_0002829, species:10090; rdf:object sub:_2; rdf:predicate belv:decreases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "p(MGI:Hes6) -| p(MGI:Hes1)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_5; pav:version "20131211" . sub:_4 prov:value "In Min6, Hes6 overexpression decreased the level of Hes1 mRNA by 54% (P<0.05; Fig. 4A) and reduced the level of Hes1 protein as well (Fig. 3C). PDX1, NeuroD and MafA mRNA levels were all significantly increased (2.7-, 1.7-, and 1.6-fold respectively, P<0.05), but the levels of mouse insulin I and II mRNA were unchanged, suggesting that neither the insulin transactivators nor Hes1 are limiting insulin gene expression (Fig. 4A). "; prov:wasQuotedFrom pubmed:17300753 . sub:_5 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:17300753; prov:wasDerivedFrom beldoc:, sub:_4 . } sub:pubinfo { this: dct:created "2014-07-03T14:33:08.513+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }